(Total Views: 765)
Posted On: 07/20/2022 3:23:27 PM
Post# of 145247
I would not bet money on GSK doing a deal. But maraviroc has gone nowhere and it's owned by a competitor to his current company. Wood undoubtedly knows about leronlimab and he'd be a hero in GSK if he made a deal on leronlimab once it proved a success. He also must have performance bonuses. Never underestimate the incentive of money.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)